SCHEMBL30939816

SCHEMBL30939816

CCCCCCCCCCCCCCCCOCCCO[P@@](=O)(OCOC(=O)OC(C)C)OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](OC(=O)C(C)(C)C)[C@@H]1OC(=O)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31684104 1.00 — —
SCHEMBL31684202 1.00 — —
SCHEMBL31684130 0.93 TMPRSS2 (0.30) —
SCHEMBL31684099 0.93 TMPRSS2 (0.30) —
SCHEMBL31684150 0.93 TMPRSS2 (0.30) —
SCHEMBL31684117 0.93 TMPRSS2 (0.30) —
SCHEMBL30939836 0.93 TMPRSS2 (0.30) —
SCHEMBL31684100 0.93 TMPRSS2 (0.30) —
SCHEMBL31684243 0.92 — —
SCHEMBL31684172 0.92 TMPRSS2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4617278-A1 NUCLEOTIDE ANALOG, AND COMPOSITION AND USE THEREOF Shenzhen TargetRx, Inc. (CN) 2025-09-17 — — EP disclosed
WO-2024120464-A1 NUCLEOTIDE ANALOG, AND COMPOSITION AND USE THEREOF 深圳市塔吉瑞生物医药有限公司 2024-06-13 — — WO disclosed
Send feedback